CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current assets
Cash and cash equivalents	$ 46,610	$ 54,721
Grant receivables	2,526	1,799
Prepaid expenses and other current assets	1,794	2,005
Other receivables	2	467
Total current assets	50,932	58,992
Property and equipment, net	246	145
Right-of-use assets, operating leases	691
Other assets	1,688
Total assets	53,557	59,137
Current liabilities
Accounts payable	8,087	4,168
Accrued expenses	2,314	1,751
Deferred grant income, current	1,601	753
Operating lease liabilities, current	114
Other current liabilities		1,192
Total current liabilities	12,116	7,864
Operating lease liabilities, noncurrent	603
Deferred grant income and other liabilities, noncurrent	1,518
Total liabilities	14,237	7,864
Commitments and contingencies (Note 6)
Stockholders' equity:
Preferred stock, $0.001 par value, 10,000,000 shares authorized; no shares issued and outstanding at September 30, 2022 and December 31, 2021
Common stock, $0.001 par value, 250,000,000 shares authorized; 23,969,497 and 22,230,032 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively	24	22
Additional paid-in capital	149,716	145,453
Accumulated deficit	(110,219)	(94,004)
Accumulated other comprehensive loss	(201)	(198)
Total stockholders' equity	39,320	51,273
Total liabilities and stockholders' equity	$ 53,557	$ 59,137

The amount of current portion of deferred grant income as at the end of the reporting period.

No definition available.

Name:	cgtx_DeferredGrantIncomeCurrent
Namespace Prefix:	cgtx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).